Outset Medical Inc (NASDAQ: OM)’s stock price has soared by 16.12 in relation to previous closing price of 0.53. Nevertheless, the company has seen a gain of 6.96% in its stock price over the last five trading days. accesswire.com reported 2024-09-29 that NEW YORK, NY / ACCESSWIRE / September 29, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=106003&wire=1 or contact Joseph E. Levi, Esq.
Is It Worth Investing in Outset Medical Inc (NASDAQ: OM) Right Now?
The 36-month beta value for OM is at 1.91. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 2 rating it as “overweight,” 3 as “hold,” and 1 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for OM is 47.78M, and currently, shorts hold a 9.18% of that float. The average trading volume for OM on September 30, 2024 was 1.99M shares.
OM’s Market Performance
The stock of Outset Medical Inc (OM) has seen a 6.96% increase in the past week, with a -1.11% drop in the past month, and a -84.08% fall in the past quarter. The volatility ratio for the week is 10.72%, and the volatility levels for the past 30 days are at 13.06% for OM. The simple moving average for the past 20 days is 15.75% for OM’s stock, with a -80.15% simple moving average for the past 200 days.
Analysts’ Opinion of OM
Many brokerage firms have already submitted their reports for OM stocks, with RBC Capital Mkts repeating the rating for OM by listing it as a “Sector Perform.” The predicted price for OM in the upcoming period, according to RBC Capital Mkts is $3 based on the research report published on August 08, 2024 of the current year 2024.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see OM reach a price target of $6, previously predicting the price at $5. The rating they have provided for OM stocks is “Outperform” according to the report published on June 21st, 2024.
BTIG Research gave a rating of “Buy” to OM, setting the target price at $6 in the report published on April 08th of the current year.
OM Trading at -60.28% from the 50-Day Moving Average
After a stumble in the market that brought OM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.54% of loss for the given period.
Volatility was left at 13.06%, however, over the last 30 days, the volatility rate increased by 10.72%, as shares surge +9.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -84.82% lower at present.
During the last 5 trading sessions, OM rose by +6.96%, which changed the moving average for the period of 200-days by -88.89% in comparison to the 20-day moving average, which settled at $0.5324. In addition, Outset Medical Inc saw -88.67% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OM starting from Trigg Leslie, who sale 5,308 shares at the price of $0.84 back on Aug 15 ’24. After this action, Trigg Leslie now owns 910,496 shares of Outset Medical Inc, valued at $4,459 using the latest closing price.
Nash Marc, the SVP Operations and R&D of Outset Medical Inc, sale 1,293 shares at $0.84 during a trade that took place back on Aug 15 ’24, which means that Nash Marc is holding 239,397 shares at $1,086 based on the most recent closing price.
Stock Fundamentals for OM
Current profitability levels for the company are sitting at:
- -1.29 for the present operating margin
- 0.28 for the gross margin
The net margin for Outset Medical Inc stands at -1.37. The total capital return value is set at -0.56. Equity return is now at value -126.48, with -49.06 for asset returns.
Based on Outset Medical Inc (OM), the company’s capital structure generated 0.74 points at debt to capital in total, while cash flow to debt ratio is standing at -0.69. The debt to equity ratio resting at 2.9. The interest coverage ratio of the stock is -8.09.
Currently, EBITDA for the company is -153.79 million with net debt to EBITDA at -1.16. When we switch over and look at the enterprise to sales, we see a ratio of 1.69. The receivables turnover for the company is 3.41for trailing twelve months and the total asset turnover is 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.80.
Conclusion
In conclusion, Outset Medical Inc (OM) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
